Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling

被引:18
|
作者
Ha, Sookhee N.
Hey, Pat J.
Ransom, Rick W.
Bock, Mark G.
Su, Dai-Shi
Murphy, Kathryn L.
Chang, Ray
Chen, Tsing-Bau
Pettibone, Douglas
Hess, J. Fred
机构
[1] Merck Res Labs, Basic Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Med Chem & Neurosci, West Point, PA 19486 USA
[3] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA
关键词
D O I
10.1021/bi060673f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the critical residues for the interaction of the kinins with human bradykinin receptor 1 (B1) using site- directed mutagenesis in conjunction with molecular modeling of the binding modes of the kinins in the homology model of the B1 receptor. Mutation of Lys(118) in transmembrane (TM) helix 3, Ala(270) in TM6, and Leu(294) in TM7 causes a significant decrease in the affinity for the peptide agonists des- Arg(10)kallidin (KD) and des- Arg(9)BK but not the peptide antagonist des- Arg(10)Leu(9)KD. In contrast, mutations in TM2, TM3, TM6, and TM7 cause a significant decrease in the affinity for both the peptide agonists and the antagonist. These data indicate that the B1 bradykinin binding pocket for agonists and antagonists is similar, but the manners in which they interact with the receptor do not completely overlap. Therefore, there is a potential to influence the receptor's ligand selectivity.
引用
收藏
页码:14355 / 14361
页数:7
相关论文
共 50 条
  • [41] IDENTIFICATION OF ACTIVE-SITE RESIDUES OF ESCHERICHIA-COLI FUMARATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
    SCHRODER, I
    GUNSALUS, RP
    ACKRELL, BAC
    COCHRAN, B
    CECCHINI, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (21) : 13572 - 13579
  • [42] ISOPENTENYL DISPHOSPHATE ISOMERASE - IDENTIFICATION OF CATALYTIC-SITE RESIDUES BY AFFINITY LABELING AND SITE-DIRECTED MUTAGENESIS
    POULTER, CD
    STREET, IP
    COFFMAN, H
    LU, XJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 201 : 90 - BIOT
  • [43] Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling
    Mialet, J
    Dahmoune, Y
    Lezoualc'h, F
    Berque-Bestel, I
    Eftekhari, P
    Hoebeke, J
    Sicsic, S
    Langlois, M
    Fischmeister, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (03) : 527 - 538
  • [44] DESIGN OF AN ANALOG OF THE GLYCOPHORIN A TRANSMEMBRANE REGION BY MOLECULAR MODELING AND SITE-DIRECTED MUTAGENESIS
    TRENTLEIN, HR
    LEMMON, MA
    ENGELMAN, DM
    BRUNGER, AT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 226 - 226
  • [45] MOLECULAR MODELING AND SITE-DIRECTED MUTAGENESIS ON A BOVINE ANTITESTOSTERONE MONOCLONAL-ANTIBODY
    JACKSON, T
    MORRIS, BA
    MARTIN, ACR
    LEWIS, DFV
    SANDERS, PG
    PROTEIN ENGINEERING, 1992, 5 (04): : 343 - 350
  • [46] Improving the binding affinity of an antibody using molecular modeling and site-directed mutagenesis
    Casipit, CL
    Tal, R
    Wittman, V
    Chavaillaz, PA
    Arbuthnott, K
    Weidanz, JA
    Jiao, JA
    Wong, HC
    PROTEIN SCIENCE, 1998, 7 (08) : 1671 - 1680
  • [47] Identification of interaction sites of cyclic nucleotide phosphodiesterase type 3A with milrinone and cilostazol using molecular modeling and site-directed mutagenesis
    Zhang, W
    Ke, H
    Colman, RW
    MOLECULAR PHARMACOLOGY, 2002, 62 (03) : 514 - 520
  • [48] Critical role of the Arg433 residue in rat transketolase as probed by site-directed mutagenesis and molecular modeling
    Soh, Y
    Kallarakal, AT
    Jeng, J
    Song, BJ
    FASEB JOURNAL, 1997, 11 (09): : A1025 - A1025
  • [49] THE LIGAND-BINDING SITE OF THE NEUROKININ-2 RECEPTOR - SITE-DIRECTED MUTAGENESIS AND IDENTIFICATION OF NEUROKININ A BINDING RESIDUES IN THE HUMAN NEUROKININ 2 RECEPTOR
    BHOGAL, N
    DONNELLY, D
    FINDLAY, JBC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (44) : 27269 - 27274
  • [50] Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor
    Martín-Martínez, M
    Marty, A
    Jourdan, M
    Escrieut, C
    Archer, E
    González-Muñiz, R
    García-López, MT
    Maigret, B
    Herranz, R
    Fourmy, D
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 4842 - 4850